Biotech

All Articles

Daiichi pays Merck $170M to form bronchi cancer T-cell engager pact

.Merck &amp Co. has swiftly redeemed a number of the costs of its Weapon Therapeutics buyout, attrac...

BioMarin standstills preclinical gene treatment for heart disease

.After BioMarin conducted a spring tidy of its pipeline in April, the firm has chosen that it likewi...

Eisai vegetations molecular glue SEED with $1.5 B biobucks handle

.Big Pharmas remain caught to the tip of molecular glue degraders. The most up to date business to f...

Life scientific research credit rating agency introduces with $600M

.A new international lifestyle scientific research debt firm, nicknamed Symbiotic Resources, has act...

BMS ditches TIGIT, ignoring $200M bank on Agenus bispecific

.Bristol Myers Squibb is axing another big wager coming from the Caforio era, canceling a package fo...

Nuvation standstills BET prevention after thinking about stage 1 information

.After having a look at stage 1 data, Nuvation Bio has actually made a decision to halt work on its ...

' Scientific instinct' led FDA consultants to support Zevra's uncommon disease med

.Zevra Rehabs' rare health condition medication seems to be on the path to confirmation this loss af...

Pfizer takes $230M struck after axing neglected DMD genetics treatment

.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) genetics treatment failing has actually gone a $23...

AC Immune observes 'spots' potential in Alzheimer's drug information

.After greater than two decades of service neurodegenerative health conditions, Swiss biotech AC Imm...

GSK loses ph. 2 HPV injection over lack of best-in-class potential

.GSK has actually ditched a phase 2 individual papillomavirus (HPV) vaccination coming from its own ...